Clinical trial

Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating…

NCT00017004 · Gynecologic Oncology Group, Other · Completed

Key facts

NCT number NCT00017004
Title Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia
Official title Phase III Trial to Evaluate the Efficacy of Maintaining Hemoglobin Levels Above 120 g/l With Erythropoietin Versus Above 100 g/l Without Erythropoietin in Anemic Patients Receiving Concurrent Radiation and Cisplatin for Cervical Cancer
Lead sponsor Gynecologic Oncology Group, Other
Collaborators Canadian Cancer Trials Group National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Anemia, Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Drug Toxicity, Radiation Toxicity, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
Intervention type Biological, Drug, Radiation
Interventions External Beam Radiation Therapy, Cisplatin, Internal Radiation Therapy, Epoetin Alfa
Enrollment 114
Start date Aug 1, 2001
Primary completion May 15, 2004
First posted Jan 27, 2003
Last update posted Aug 9, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies